Sangamo Therapeutics
SGMO
#10419
Rank
C$43.2 M
Marketcap
C$0.10
Share price
0.00%
Change (1 day)
-87.10%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of March 2026 : -C$26.72 Million

According to Sangamo Therapeutics 's latest financial reports the company has -C$26.72 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-C$19.54 Million-159.8%
2024-12-31$C$32.67 M-70.28%
2023-12-31$C$0.10 B-72.53%
2022-12-31$C$0.40 B-16.33%
2021-12-31$C$0.47 B-24.57%
2020-12-31$C$0.63 B12.21%
2019-12-31$C$0.56 B12.97%
2018-12-31$C$0.50 B111.77%
2017-12-31$C$0.23 B29.07%
2016-12-31$C$0.18 B-31.44%
2015-12-31$C$0.26 B11.33%
2014-12-31$C$0.23 B85.08%
2013-12-31$C$0.12 B100.77%
2012-12-31$C$64.53 M-20.83%
2011-12-31$C$81.51 M45.85%
2010-12-31$C$55.88 M-26.01%
2009-12-31$C$75.52 M12.13%
2008-12-31$C$67.35 M-6.38%
2007-12-31$C$71.94 M26.88%
2006-12-31$C$56.7 M28.81%
2005-12-31$C$44.02 M13.21%
2004-12-31$C$38.88 M-32.88%
2003-12-31$C$57.93 M-32.38%
2002-12-31$C$85.67 M-34.69%
2001-12-31$C$0.13 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
C$114.40 B-428,409.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.95 B-48,583.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$26.28 B-98,499.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C$23.62 B-88,535.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$33.01 B-123,713.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$64.72 B-242,416.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.51 B-5,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$8.75 B-32,872.94%๐Ÿ‡บ๐Ÿ‡ธ USA